USPTO serial 79213966
MENOVO
Reviewed by CopyMark Law Group
Reg. 5477856Status 709
- Filing date
- Status date
- Registration date
- May 29, 2018
- Examiner
- ROACH, APRIL K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MENOVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Zhejiang, CN
Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Zhejiang, CN
Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Zhejiang, CN
Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for antibiotics, the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer, gastrointestinal diseases and coughs; syrups for pharmaceutical purposes for the treatment of coughs; pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; chemico-pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; analgesics; drugs for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; vermicide for human or veterinary use; anthelmintics for human or veterinary use; medical pills for the relief of pain and for the treatment of headache, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; capsules for pharmaceutical purposes for the relief of allergy and pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; sedatives; biological preparations for medical purposes for antibiotics, for the prevention and treatment of infectious diseases and for the treatment of cancer; chemical preparations for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; injectable pharmaceuticals for the treatment of cancer, immunosuppression and infection; medicinal preparations for the mouth to be applied in the form of tablets for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; active pharmaceutical ingredient for the relief of pain and for the treatment of inflammation, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
- Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
- Other trademarks owned by NINGBO MENOVO PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named MENOVO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 1, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 1, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 13, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 13, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 29, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 14, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 14, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 29, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 29, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 21, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 21, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 17, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |